Transoral robotic surgery

Abstract

Historically, advanced oropharyngeal cancer has been treated by surgical excision and postoperative radiotherapy. In this decade, many authors advocate for chemoradiotherapy to avoid impairments after surgery. But it also induced significant impairments in swallowing. Transoral robotic surgery (TORS) provides new benchmarks of function and complication rates, with which other series of treatments for oropharyngeal SCC can be compared. In Japan, we cannot do this procedure now, but we have to prepare.